The Association Between Type 2 Diabetes Mellitus and the Development of Chronic Kidney Disease: A Literature Review of Foundational Evidence

Abstract

Introduction: Type 2 Diabetes Mellitus (T2DM) has long been recognised as a global health crisis, not only for its metabolic dysregulation but also for its severe long-term complications. Among these, Chronic Kidney Disease (CKD), often termed diabetic nephropathy, is a major cause of morbidity and mortality. This review synthesises the foundational scientific literature published before 2010 that established the causal link between T2DM and the onset and progression of CKD.

Literature Review: Epidemiological data from the late 20th century firmly established T2DM as the leading cause of end-stage renal disease in the developed world. Foundational studies elucidated the natural history of diabetic nephropathy, beginning with glomerular hyperfiltration and progressing to microalbuminuria, overt proteinuria, and an eventual decline in the glomerular filtration rate. The pathophysiological basis was uncovered, identifying chronic hyperglycemia as the primary driver of renal damage through mechanisms such as the formation of advanced glycation end-products (AGEs), activation of protein kinase C, and upregulation of the renin-angiotensin-aldosterone system (RAAS). Landmark clinical trials, most notably the United Kingdom Prospective Diabetes Study (UKPDS), provided conclusive evidence that intensive glycemic control could significantly reduce the risk of developing microvascular complications, including nephropathy.

Conclusion: The literature reviewed provides unequivocal evidence that T2DM is a primary and direct cause of CKD. The pathway from hyperglycemia to renal failure is well-defined, and interventions aimed at intensive glycemic and blood pressure control were proven to be effective cornerstones for preventing or slowing the progression of diabetic kidney disease.